India Buy Now Pay Later Business Report 2023: BNPL Payments are Expected to Grow by 20.5% to Reach $14.7 Billion in 2023 – Forecasts to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Buy Now Pay Later Business and Investment Opportunities Databook – 75+ KPIs on BNPL Market Size, End-Use... Read more.
Stratasys Releases Third Quarter 2023 Financial Results
Revenue of $162.1 million, essentially flat with third quarter 2022, up 3.3% at constant currency excluding MakerBot and Stratasys Direct divestments Record-level... Read more.
Delta Galil Reports Third Quarter 2023 Results
Third Quarter Results Reflect Significant Progress on Initiatives Aimed at Expanding Gross Margin, Reducing Inventory, Driving Operating Cash Flow and Strengthening... Read more.
Sunnova Expands Cutting-Edge Global Command Center, Redefining Customer Service in the Solar Industry
Investing in and bolstering service capabilities for its network of residential and commercial customers HOUSTON–(BUSINESS WIRE)–Sunnova Energy International... Read more.
Cybin to Release Phase 2 Topline Safety and Efficacy Data for CYB003 in Major Depressive Disorder and Host R&D Briefing on November 30, 2023
– Company to share topline Phase 2 safety and efficacy data for CYB003, its deuterated psilocybin analog being developed for the treatment of major depressive... Read more.
Tradeweb to Acquire Algorithmic Technology Provider r8fin
Acquisition Will Further Enhance and Differentiate Tradeweb Intelligent Execution Capabilities in Fixed Income and Futures NEW YORK–(BUSINESS WIRE)–Tradeweb... Read more.
NEUPATH HEALTH REPORTS THIRD QUARTER 2023 RESULTS
Third quarter total revenue of $16.1 million, up 6% year-over-year Adjusted EBITDA(1) of $0.7 million, our 19th consecutive quarter of positive adjusted EBITDA and... Read more.
Johnson & Johnson to Host Enterprise Business Review
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) (the ‘Company’) will hold an Enterprise Business Review for the investment... Read more.
Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health... Read more.
Arrowhead Pharmaceuticals to Webcast Fiscal 2023 Year End Results
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference... Read more.